{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_7144", "batch_size": 200, "batch_pos": 91, "statement_text": "In a previous briefing, O'Connell said her agency was also negotiating with Pfizer for an mRNA vaccine against H5N1.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment discusses negotiations factually, lacking high-potency framing.", "method": "llm_batch", "batch_id": "batch_2_8916", "batch_size": 200, "batch_pos": 58, "statement_text": "In a previous briefing, O'Connell said her agency was also negotiating with Pfizer for an mRNA vaccine against H5N1.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "Describes a potential future availability ('could be available'), not realised impact.", "method": "llm_batch", "batch_id": "batch_3_21352", "batch_size": 200, "batch_pos": 7, "statement_text": "In a previous briefing, O'Connell said her agency was also negotiating with Pfizer for an mRNA vaccine against H5N1.", "article_id": 1745}
